RRC Q1 2026 Earnings Strong Earnings Beat Driven by Operational Efficiency and Cost Controls XXII Q1 2026 Earnings Significant EPS Miss Highlights Continued Challenges BLK Q1 2026 Earnings Strong EPS Beat Driven by Fee Income and Asset Growth Kestrel Group Ltd Q3 2024 Earnings Loss Per Share of 016 Triggers Stock Decline SBSI Q1 2026 Earnings EPS Beat of 422 Despite Tightening Margin Environment Texas Capital Bancshares Preferred Stock TCBIO Holds Steady Near Key Levels Blackstone Senior Floating Rate 2027 Term Fund BSL Holds Steady at 1305 Key Levels in Focus Dr Reddys Labs RDY Edges Higher Testing Key Resistance Levels Hoth Therapeutics Soars Over 86 Volatile Session Pushes Key Technical Levels into Focus Halozyme Therapeutics Q1 2026 Earnings EPS Beat Drives Modest Positive Surprise Despite Flat Revenue Disclosure